Clinical needs of patients with disabilities are seen with the “medical gaze,” a depersonalized lens of evidence-based medicine and of presumed objectivity.
AMA J Ethics. 2023;25(1):E85-87. doi:
10.1001/amajethics.2023.85.
Dr Adam T. Perzynski joins Ethics Talk to discuss his article, coauthored with Dr Kurt C. Stange: “How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters?”
This commentary on a case considers a transgender patient’s mental health and risk for DVT in ethical decision making about feminizing gender-affirming hormone therapy.
AMA J Ethics. 2023;25(6):E386-390. doi:
10.1001/amajethics.2023.386.
Annika Brakebill, A. Mark Fendrick, MD, and Jeffrey T. Kullgren, MD, MS, MPH
These key steps are ones health sector stakeholders should take to help patients and clinicians use pricing information to inform health decision making.
AMA J Ethics. 2022;24(11):E1034-1039. doi:
10.1001/amajethics.2022.1034.
Watie White joins Ethics Talk to discuss his article, coauthored with Dr Regina Idoate, Aislinn C. Rookwood, Sophia A. Quintero, Shelby Larson, Dr Arturo Aceves, and Dr Keyonna M. King: “Lead Toxicity and Environmental Health Justice Stories in Black and White Woodcut Portraits.”